ArticleJournal of neuroinflammation2023

Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis.

Barbara Nuesslein-Hildesheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.